Valuation Black Diamond Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 21:00:00 27/08/2026 BST			5-day change	1st Jan Change
2.270 ^USD	0.00%		+5.58%	-6.58%

08-05	Black Diamond Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-29	Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	193.1	65.46	145.1	121.1	138.4	130.4	-	-
Change	-	-66.1%	121.66%	-16.54%	14.33%	-5.8%	-	-
Enterprise Value (EV)	-16.69	-57.35	145.1	121.1	138.4	130.4	130.4	130.4
Change	-	-243.68%	353.01%	-16.54%	14.33%	-5.8%	0%	0%
P/E	-1.54x	-0.71x	-1.49x	-1.69x	6.23x	-3.68x	-2.38x	-2.45x
PBR	0.98x	-	-	-	-	-	-	-
PEG	-	0x	0.1x	0.1x	-0x	0x	-0x	0.87x
Capitalization / Revenue	-	-	-	-	1.98x	20.9x	-	-
EV / Revenue	-	-	-	-	0x	20.9x	-	-
EV / EBITDA	0x	0x	-	-0x	0x	-2.69x	-1.96x	-1.6x
EV / EBIT	0x	0x	-0x	-0x	0x	-3.02x	-1.89x	-1.42x
EV / FCF	0x	0x	-0x	-0x	0x	-2.96x	-2.96x	8.15x
FCF Yield	-53.3%	-130%	-46%	-51.5%	21.4%	-33.7%	-33.7%	12.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3.47	-2.52	-1.88	-1.27	0.39	-0.6162	-0.9525	-0.9257
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	70	6.25	-	-
EBITDA ¹	-126.7	-92.32	-	-78.44	20.2	-48.52	-66.52	-81.66
EBIT ¹	-126.9	-92.83	-86.46	-78.78	19.87	-43.14	-69.02	-91.83
Net income ¹	-125.6	-91.17	-82.44	-69.68	22.37	-36.96	-64.65	-87.39
Net Debt	-209.8	-122.8	-	-	-	-	-	-
Reference price ²	5.330	1.800	2.810	2.140	2.430	2.270	2.270	2.270
Nbr of stocks (in thousands)	36,229	36,366	51,635	56,585	56,975	57,454	-	-
Announcement Date	17/03/22	09/03/23	12/03/24	06/03/25	16/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BLACK DIAMOND THERAPEUTICS, INC.	-3.68x	-	-	-	130M
WUXI APPTEC CO., LTD.	20.97x	7.35x	14.98x	1.41%	70.42B
ARGENX SE	37.32x	9.68x	29.71x	0.04%	65.4B
BIONTECH SE	-17.15x	7.14x	-8.98x	-.--%	28.28B
WUXI BIOLOGICS (CAYMAN) INC.	30.86x	6.62x	17.71x	-.--%	26.57B
INSMED INCORPORATED	-78.62x	14.69x	-70.84x	-.--%	27.16B
GENMAB A/S	27.31x	5.12x	17.18x	-.--%	20.09B
PHARMAESSENTIA CORPORATION	59.78x	22.25x	45.14x	0.25%	20.61B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1692.68x	39.78x	868.6x	-.--%	15.87B
EXELIXIS, INC.	17.35x	5.16x	12.03x	-.--%	13.9B
Average	178.68x	13.09x	102.84x	0.19%	28.84B
Weighted average by Cap.	107.49x	11.07x	57.30x	0.37%